A detailed history of Black Rock Inc. transactions in Organogenesis Holdings Inc. stock. As of the latest transaction made, Black Rock Inc. holds 4,974,301 shares of ORGO stock, worth $12.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,974,301
Previous 5,198,187 4.31%
Holding current value
$12.4 Million
Previous $21.3 Million 33.55%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$2.61 - $4.49 $584,342 - $1.01 Million
-223,886 Reduced 4.31%
4,974,301 $14.1 Million
Q4 2023

Feb 13, 2024

BUY
$1.97 - $4.21 $498,482 - $1.07 Million
253,037 Added 5.12%
5,198,187 $21.3 Million
Q3 2023

Nov 13, 2023

BUY
$2.34 - $4.43 $233,665 - $442,366
99,857 Added 2.06%
4,945,150 $15.7 Million
Q2 2023

Aug 11, 2023

BUY
$1.9 - $4.3 $677,692 - $1.53 Million
356,680 Added 7.95%
4,845,293 $16.1 Million
Q1 2023

May 12, 2023

SELL
$1.89 - $2.93 $12.5 Million - $19.4 Million
-6,614,577 Reduced 59.57%
4,488,613 $9.56 Million
Q4 2022

Feb 13, 2023

BUY
$2.48 - $3.43 $1.4 Million - $1.94 Million
566,429 Added 5.38%
11,103,190 $29.9 Million
Q3 2022

Nov 14, 2022

BUY
$3.14 - $6.43 $2.71 Million - $5.54 Million
861,588 Added 8.91%
10,536,761 $34.1 Million
Q2 2022

Aug 12, 2022

BUY
$4.74 - $8.15 $108,948 - $187,327
22,985 Added 0.24%
9,675,173 $47.2 Million
Q1 2022

May 12, 2022

BUY
$6.47 - $9.57 $9.14 Million - $13.5 Million
1,412,356 Added 17.14%
9,652,188 $73.6 Million
Q4 2021

Feb 10, 2022

BUY
$9.02 - $13.5 $1.49 Million - $2.24 Million
165,724 Added 2.05%
8,239,832 $76.1 Million
Q3 2021

Nov 09, 2021

BUY
$13.71 - $17.18 $14.4 Million - $18.1 Million
1,052,935 Added 15.0%
8,074,108 $115 Million
Q2 2021

Aug 11, 2021

BUY
$14.92 - $23.23 $105 Million - $163 Million
7,021,173 New
7,021,173 $117 Million

Others Institutions Holding ORGO

About Organogenesis Holdings Inc.


  • Ticker ORGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 130,888,000
  • Market Cap $327M
  • Description
  • Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...
More about ORGO
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.